PERRY A KARSEN Insider Trading $NAVB NAVIDEA BIOPHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PERRY A KARSEN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PERRY A KARSEN. PERRY A KARSEN is see remarks in CELGENE CORP /DE/ ($CELG) and Senior Vice President in HUMAN GENOME SCIENCES INC ($HGSI) and Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Director in OncoMed Pharmaceuticals Inc ($OMED) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Voyager Therapeutics, Inc. ($VYGR) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Intellia Therapeutics, Inc. ($NTLA).

PERRY A KARSEN in NAVIDEA BIOPHARMACEUTICALS, INC.

Trading Symbol: NAVB
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of PERRY A KARSEN: Director
Holdings: 37,528 shares
Current Value: $19,515
Latest Transaction: Jul 21 2015
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PERRY A KARSEN in NAVIDEA BIOPHARMACEUTICALS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AGIO, CELG, HGSI, NTLA, JNCE, NAVB, OMED, VYGR

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jul 21 2015	NAVB	NAVIDEA BIOPHARMAC ...	KARSEN PERRY A	Director	Sell	D	0.01	22,000	220	37,528	59.5 K to 37.5 K (-36.96 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	KARSEN PERRY A	Director	Grant	A	0.00	22,000	0	59,528	37.5 K to 59.5 K (+58.62 %)

Page: 1